Alzamend Neuro, Inc.
ALZN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001677077
In the last 90 days, Alzamend Neuro, Inc. insiders filed 1 open-market purchase and 1 sale; 12 institutions reported holding it in 13F filings for Q2 2026, worth $3.26M in total; no superinvestor holds it.
Q1 2026 vs. Q4 2025
How the institutions holding Alzamend Neuro, Inc. changed between Q4 2025 and Q1 2026.
All holders in Q1 2026All holders in Q4 2025
| Measure | Q4 2025 | Of which not filed for Q1 2026 | Q1 2026 | Change |
|---|---|---|---|---|
| Holders | 13 | 1 | 13 | +1 |
| Shares | 245.6K | 21.6K | 682.2K | +458.2K (+204.5%) |
| Value | $447.2K | $39.3K | $723.1K | +$315.3K (+77.3%) |
1 institution that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so the changes leave them out.
New holders (5)
Institutions that held Alzamend Neuro, Inc. at the end of Q1 2026 but not at the end of Q4 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Kingsbury Capital Investment Advisors LLC | 566,733 | $600.7K | 0.56% |
| Vanguard Fiduciary Trust Co | 21,020 | $22.3K | 0.00% |
| Citigroup Inc | 5,231 | $5.54K | 0.00% |
| Vanguard Capital Management LLC | 4,400 | $4.66K | 0.00% |
| Caitong International Asset Management Co., Ltd | 4 | $4 | 0.00% |
Sold out (4)
Institutions that held Alzamend Neuro, Inc. at the end of Q4 2025 and filed for Q1 2026 without it.
| Institution | Shares, Q4 2025 | Value, Q4 2025 |
|---|---|---|
| DRW Securities, LLC | 116,319 | $211.7K |
| Virtu Financial LLC | 12,582 | $23.0K |
| XTX Topco Ltd | 12,470 | $22.7K |
| Bank of America Corp | 43 | $78 |
Not filed for Q1 2026 yet (1)
Institutions that held Alzamend Neuro, Inc. at the end of Q4 2025 and haven't filed a 13F for Q1 2026. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2025 | Value, Q4 2025 |
|---|---|---|
| Vanguard Group Inc | 21,620 | $39.3K |